CONGRESS PRESIDENTS: Olivier Glehen (Lyon, France), Martin Hübner (Lausanne, Switzerland), Hyung-Ho Kim (Seoul, South Korea),

Michael Bau Mortensen (Odense, Denmark), Marc Pocard (Paris, France), Marc Reymond (Tübingen, Germany), Jimmy So (Singapore)

SYMPOSIUM

5TH INTERNATIONAL

UNDERSTANDING PERITONEAL METASTASIS

September 7th & 8th 2018FONDATION DOSNE-THIERS, PARIS, FRANCE

www.pipac.fr FINAL PROGRAM

SYMPOSIUM

5TH INTERNATIONAL

UNDERSTANDING PERITONEAL METASTASIS

FINAL PROGRAM

Friday, September 7th

07:15 Welcome desk opening

SESSION 1 – TECHNOLOGY SESSION

08:00 HINAT, S. Reck (Stuttgart, Germany)

08:15 PIPAC, P. Horvath (Tübingen, Germany)

08:30 ePIPAC, I. Sautkin (Omsk, Russia)

08:45 hPIPAC, H. H. Kim (Seoul, South Korea)

SESSION 2 – PHARMACOLOGY SESSION, PHASE-I STUDIES

09:00 Dose escalation study of PIPAC with oxaliplatin, J. So (Singapore)

09:15 PIPOX, F. Dumont (Nantes, France)

09:30 nab-Paclitaxel, W. Willaert (Gent, Belgium)

09:45 ePIPAC, K. Rovers (Eindhoven, The Netherlands)

10:00 Coffee break

SESSION 3 – STATE OF THE ART LECTURES

10:30 PIPAC in ovarian cancer: state of the art, C. B. Tempfer (Herne, Germany)

11:00 PIPAC in gastrointestinal cancer: state of the art, M. Hübner (Lausanne, Switzerland)

11:30 International Society for the study of Pleura and Peritoneum (ISSPP), M. A. Reymond (Tübingen, Germany)

12:00 Lunch

SESSION 4 – CLINICAL STUDIES: PHASE-2

13:00 PIPAC-GA1, F. Struller (Tübingen, Germany)

13:15 PIPAC-GA2, V. Khomiakov (Moskow, Russia)

13:30 PARROT, G. Vizzielli (Rome, Italy)

13:45 PI-CaP, M. Robella (Turin, Italy) 14:00 PIPAC-OPC2 & PIPAC-OPC3,

M. Graversen (Odense, Denmark)

14:15 Pause

SESSION 5 – CLINICAL STUDIES: RANDOMIZED TRIALS

14:45 PMGA-PIPAC, B. Rau (Berlin, Germany)

15:00 uGI-PIPAC, T. Goetze (Frankfurt, Germany)

15:15 PIPAC in platin-resistant ovarian cancer: a randomized trial, S. P. Somashekhar (Bengalore, India)

15:30 Quality of life assessment under PIPAC therapy: a randomized trial, S. P. Somashekhar (Bengalore, India)

15:45 PIPAC-Estok, C. Eveno (Paris, France)

16:00 PIPAC-OV3, N. Bakrin (Lyon, France)

16:15 CRC-PIPAC 2, K. Rovers (Eindhoven, The Netherlands)

16:30 GC-PIPAC 2, K. Rovers (Eindhoven, The Netherlands)

16:45 Summary of the day

17:00 End of the day

19:30 Gala dinner

SYMPOSIUM

5TH INTERNATIONAL

UNDERSTANDING PERITONEAL METASTASIS

FINAL PROGRAM

Saturday, September 8th

WORKING GROUPS

ROOM A

08:00 PIPAC-0V3 trial study meeting*, N. Bakrin (Lyon, France)

ROOM B

08:00 PRGS pathology meeting*, W. Solass (Tübingen, Germany)

ROOM C

08:00 Workshop Scanning Electron Microscope*, C. Pape (Darmstadt, Germany)

ROOM E

08:00 PIPAC international registry*, M. B. Mortensen (Odense, Denmark)

CONFEENCE ROOM

08:00 Free papers presentation, W. Ceelen (Ghent, Belgium) & R. Wilson (Sidney, Australia)

10:00 Coffee break

CHARLES SURH LECTURE

10:30 Laudatio, M. A. Reymond (Tübingen, Germany)

From Huang Di to Henry Head - 2000 years of segmental phenomena, F. Beissner (Hanover, Germany)

INTERNATIONAL SOCIETY FOR THE STUDY OF PLEURA AND PERITONEUM

M. Pocard (Paris, France)

11:00 Creation of the society Approval of statute Election of the first president Election of the executive committee Press release Official picture in the historical library

12:00 Award for the best communication, W. Ceelen (Ghent, Belgium) & R. Wilson (Sidney, Australia)

Invitation to the 6th PIPAC meeting, Singapore 2019, J. So (Singapore)

12:15 Farewell, M. Pocard (Paris, France)

SCIENTIFIC COMMITTEE

ACKNOWLEDGMENTSMAJOR SPONSOR

GI TUMORSPr Clarisse EvenoDr Philipp HorvathPr Martin HubnerDr Florian StrullerGYNECOLOGYPr Clemens TempferEXPERIMENTALPr Wim CeelenPr Marc PocardPr Robert Wilson

PHARMACOLOGYDr Ranjita SahooTECHNOLOGYPr Marc ReymondCLINICAL, PATHOLOGYDr Wiebke SolassSTATISTICSDr Tarkan Jäger

*On invitation.

SPONSORS